Frontiers in Genetics,
Journal Year:
2023,
Volume and Issue:
14
Published: March 13, 2023
RNA
sequencing
(RNA-seq)
has
become
an
exemplary
technology
in
modern
biology
and
clinical
science.
Its
immense
popularity
is
due
large
part
to
the
continuous
efforts
of
bioinformatics
community
develop
accurate
scalable
computational
tools
analyze
enormous
amounts
transcriptomic
data
that
it
produces.
RNA-seq
analysis
enables
genes
their
corresponding
transcripts
be
probed
for
a
variety
purposes,
such
as
detecting
novel
exons
or
whole
transcripts,
assessing
expression
alternative
studying
splicing
structure.
It
can
challenge,
however,
obtain
meaningful
biological
signals
from
raw
because
scale
well
inherent
limitations
different
technologies,
amplification
bias
biases
library
preparation
.
The
need
overcome
these
technical
challenges
pushed
rapid
development
tools,
which
have
evolved
diversified
accordance
with
technological
advancements,
leading
current
myriad
tools.
These
combined
diverse
skill
sets
biomedical
researchers,
help
unlock
full
potential
RNA-seq.
purpose
this
review
explain
basic
concepts
define
discipline-specific
jargon.
Nucleic Acids Research,
Journal Year:
2020,
Volume and Issue:
48(W1), P. W509 - W514
Published: May 17, 2020
Abstract
Tumor
progression
and
the
efficacy
of
immunotherapy
are
strongly
influenced
by
composition
abundance
immune
cells
in
tumor
microenvironment.
Due
to
limitations
direct
measurement
methods,
computational
algorithms
often
used
infer
cell
from
bulk
transcriptome
profiles.
These
estimated
infiltrate
populations
have
been
associated
with
genomic
transcriptomic
changes
tumors,
providing
insight
into
tumor–immune
interactions.
However,
such
investigations
on
large-scale
public
data
remain
challenging.
To
lower
barriers
for
analysis
complex
interactions,
we
significantly
improved
our
previous
web
platform
TIMER.
Instead
just
using
one
algorithm,
TIMER2.0
(http://timer.cistrome.org/)
provides
more
robust
estimation
infiltration
levels
The
Cancer
Genome
Atlas
(TCGA)
or
user-provided
profiles
six
state-of-the-art
algorithms.
four
modules
investigating
associations
between
infiltrates
genetic
clinical
features,
exploring
cancer-related
TCGA
cohorts.
Each
module
can
generate
a
functional
heatmap
table,
enabling
user
easily
identify
significant
multiple
cancer
types
simultaneously.
Overall,
server
comprehensive
visualization
functions
infiltrating
cells.
Genome Medicine,
Journal Year:
2019,
Volume and Issue:
11(1)
Published: May 24, 2019
We
introduce
quanTIseq,
a
method
to
quantify
the
fractions
of
ten
immune
cell
types
from
bulk
RNA-sequencing
data.
quanTIseq
was
extensively
validated
in
blood
and
tumor
samples
using
simulated,
flow
cytometry,
immunohistochemistry
data.quanTIseq
analysis
8000
revealed
that
cytotoxic
T
infiltration
is
more
strongly
associated
with
activation
CXCR3/CXCL9
axis
than
mutational
load
deconvolution-based
scores
have
prognostic
value
several
solid
cancers.
Finally,
we
used
show
how
kinase
inhibitors
modulate
contexture
reveal
immune-cell
underlie
differential
patients'
responses
checkpoint
blockers.Availability:
available
at
http://icbi.at/quantiseq
.
Frontiers in Immunology,
Journal Year:
2020,
Volume and Issue:
11
Published: May 7, 2020
Tumor
cells
constantly
interact
with
their
microenvironment,
which
comprises
a
variety
of
immune
together
endothelial
and
fibroblasts.
The
composition
the
tumor
microenvironment
(TME)
has
been
shown
to
influence
response
checkpoint
blockade
(ICB).
ICB
takes
advantage
cell
infiltration
in
reinvigorate
an
efficacious
antitumoral
response.
In
addition
intrinsic
biomarkers,
increasing
data
pinpoint
importance
TME
guiding
patient
selection
combination
therapies.
Here,
we
review
recent
efforts
determining
how
various
components
can
resistance
ICB.
Although
large
body
evidence
points
extent
functional
orientation
T
infiltrate
as
important
therapy
response,
studies
also
confirm
role
for
other
TME,
such
B
cells,
myeloid
lineage
cancer-associated
fibroblasts
vasculature.
If
ultimate
goal
curative
cancer
therapies
is
induce
long-term
memory
may
positively
or
negatively
modulate
induction
efficient
antitumor
immunity.
emergence
novel
high-throughput
methods
analyzing
including
transcriptomics,
allowed
tremendous
developments
field,
expansion
cohorts
identification
TME-based
markers
Together,
these
open
possibility
selecting
patients
that
are
likely
respond
specific
therapies,
pave
way
personalized
medicine
oncology.
Nucleic Acids Research,
Journal Year:
2021,
Volume and Issue:
49(W1), P. W242 - W246
Published: May 3, 2021
In
2017,
we
released
GEPIA
(Gene
Expression
Profiling
Interactive
Analysis)
webserver
to
facilitate
the
widely
used
analyses
based
on
bulk
gene
expression
datasets
in
TCGA
and
GTEx
projects,
providing
biologists
clinicians
with
a
handy
tool
perform
comprehensive
complex
data
mining
tasks.
Recently,
deconvolution
tools
have
led
revolutionary
trends
resolve
RNA
at
cell
type-level
resolution,
interrogating
characteristics
of
different
types
cancer
controlled
cohorts
became
an
important
strategy
investigate
biological
questions.
Thus,
present
GEPIA2021,
standalone
extension
GEPIA,
allowing
users
multiple
interactive
analysis
results,
including
proportion
comparison,
correlation
analysis,
differential
expression,
survival
analysis.
With
experimental
could
easily
explore
large
validate
their
hypotheses
enhanced
resolution.
GEPIA2021
is
publicly
accessible
http://gepia2021.cancer-pku.cn/.
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Nov. 6, 2020
Many
computational
methods
have
been
developed
to
infer
cell
type
proportions
from
bulk
transcriptomics
data.
However,
an
evaluation
of
the
impact
data
transformation,
pre-processing,
marker
selection,
composition
and
choice
methodology
on
deconvolution
results
is
still
lacking.
Using
five
single-cell
RNA-sequencing
(scRNA-seq)
datasets,
we
generate
pseudo-bulk
mixtures
evaluate
combined
these
factors.
Both
methodologies
those
that
use
scRNA-seq
as
reference
perform
best
when
applied
in
linear
scale
normalization
has
a
dramatic
some,
but
not
all
methods.
Overall,
comparable
performance
performing
whereas
semi-supervised
approaches
show
higher
error
values.
Moreover,
failure
include
types
are
present
mixture
leads
substantially
worse
results,
regardless
previous
choices.
Altogether,
factors
affecting
task
across
different
datasets
propose
general
guidelines
maximize
its
performance.
International Journal of Surgery,
Journal Year:
2022,
Volume and Issue:
107, P. 106936 - 106936
Published: Sept. 20, 2022
Postoperative
progression
and
chemotherapy
resistance
is
the
major
cause
of
treatment
failure
in
patients
with
triple-negative
breast
cancer
(TNBC).
Currently,
there
a
lack
an
ideal
predictive
model
for
drug
sensitivity
postoperative
TNBC
patients.
Diverse
programmed
cell
death
(PCD)
patterns
play
important
role
tumor
progression,
which
has
potential
to
be
prognostic
indicator
after
surgery.Twelve
PCD
(apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
cuproptosis,
entotic
death,
netotic
parthanatos,
lysosome-dependent
autophagy-dependent
alkaliptosis,
oxeiptosis)
were
analyzed
construction.
Bulk
transcriptome,
single-cell
genomics,
clinical
information
collected
from
TCGA-BRCA,
METABRIC,
GSE58812,
GSE21653,
GSE176078,
GSE75688,
KM-plotter
cohorts
validate
model.The
machine
learning
algorithm
established
index
(CDI)
12-gene
signature.
Validated
five
independent
datasets,
high
CDI
had
worse
prognosis
surgery.
Two
molecular
subtypes
distinct
vital
biological
processes
identified
by
unsupervised
clustering
model.
A
nomogram
performance
was
constructed
incorporating
features.
Furthermore,
associated
immune
checkpoint
genes
key
microenvironment
components
integrated
analysis
bulk
transcriptome.
are
resistant
standard
adjuvant
regimens
(docetaxel,
oxaliplatin,
etc.);
however,
they
might
sensitive
palbociclib
(an
FDA-approved
luminal
cancer).Generally,
we
novel
comprehensively
analyzing
diverse
patterns,
can
accurately
predict
user-friendly
website
created
facilitate
application
this
prediction
(https://tnbc.shinyapps.io/CDI_Model/).
Cancer Cell,
Journal Year:
2022,
Volume and Issue:
40(12), P. 1503 - 1520.e8
Published: Nov. 10, 2022
Non-small
cell
lung
cancer
(NSCLC)
is
characterized
by
molecular
heterogeneity
with
diverse
immune
infiltration
patterns,
which
has
been
linked
to
therapy
sensitivity
and
resistance.
However,
full
understanding
of
how
phenotypes
vary
across
different
patient
subgroups
lacking.
Here,
we
dissect
the
NSCLC
tumor
microenvironment
at
high
resolution
integrating
1,283,972
single
cells
from
556
samples
318
patients
29
datasets,
including
our
dataset
capturing
low
mRNA
content.
We
stratify
into
immune-deserted,
B
cell,
T
myeloid
subtypes.
Using
bulk
genomic
clinical
information,
identify
cellular
components
associated
histology
genotypes.
then
focus
on
analysis
tissue-resident
neutrophils
(TRNs)
uncover
distinct
subpopulations
that
acquire
new
functional
properties
in
tissue
microenvironment,
providing
evidence
for
plasticity
TRNs.
Finally,
show
a
TRN-derived
gene
signature
anti-programmed
death
ligand
1
(PD-L1)
treatment
failure.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Jan. 19, 2022
Mapping
cell
types
across
a
tissue
is
central
concern
of
spatial
biology,
but
type
abundance
difficult
to
extract
from
gene
expression
data.
We
introduce
SpatialDecon,
an
algorithm
for
quantifying
populations
defined
by
single
sequencing
within
the
regions
studies.
SpatialDecon
incorporates
several
advancements
in
deconvolution.
propose
harnessing
log-normal
regression
and
modelling
background,
outperforming
classical
least-squares
methods.
compile
profile
matrices
75
types.
identify
genes
whose
minimal
cancer
cells
makes
them
suitable
immune
deconvolution
tumors.
Using
lung
tumors,
we
create
dataset
benchmarking
methods
against
marker
proteins.
simple
flexible
tool
mapping
It
obtains
estimates
that
are
spatially
resolved,
granular,
paired
with
highly
multiplexed